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Disease gene discovery in neurodevelopmental disorders, including X-linked intellectual
disability (XLID) has recently been accelerated by next-generation DNA sequencing
approaches. To date, more than 100 human X chromosome genes involved in neuronal
signaling pathways and networks implicated in cognitive function have been identified.
Despite these advances, the mutations underlying disease in a large number of XLID
families remained unresolved. We report the resolution of MRX78, a large family with
six affected males and seven affected females, showing X-linked inheritance. Although
a previous linkage study had mapped the locus to the short arm of chromosome
X (Xp11.4-p11.23), this region contained too many candidate genes to be analyzed
using conventional approaches. However, our X-chromosome exome resequencing,
bioinformatics analysis and inheritance testing revealed a missense mutation (c.C2366T,
p.A789V) in IQSEC2, encoding a neuronal GDP-GTP exchange factor for Arf family
GTPases (ArfGEF) previously implicated in XLID. Molecular modeling of IQSEC2 revealed
that the A789V substitution results in the insertion of a larger side-chain into a
hydrophobic pocket in the catalytic Sec7 domain of IQSEC2. The A789V change is
predicted to result in numerous clashes with adjacent amino acids and disruption of
local folding of the Sec7 domain. Consistent with this finding, functional assays revealed
that recombinant IQSEC2A789V was not able to catalyze GDP-GTP exchange on Arf6 as
efficiently as wild-type IQSEC2. Taken together, these results strongly suggest that the
A789V mutation in IQSEC2 is the underlying cause of XLID in the MRX78 family.
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INTRODUCTION
Intellectual disability (ID) is a developmental brain disorder
characterized by impaired intellectual and adaptive functions,
and can be defined by an IQ below 70 and limitations in
intellectual functioning and adaptive behaviors. As a result of
the excess in males affected by ID, and the identification of
families where ID shows clear X-linked segregation, significant
attention has focused on the genetics of X-linked intellectual
disability (XLID)—a common, clinically and genetically complex
disorder often arising from mutations in one of >100 genes
on the X chromosome. XLID may be associated with other
clinical, morphological, or behavioral symptoms (syndromic
XLID) or appear without other associated defects (non-
syndromic XLID). However, despite extensive genetic studies
using conventional linkage/candidate gene analysis or analysis
of copy number variants (CNVs), for a significant number of
families, the underlying cause of XLID has remained unclear.
Fortunately, the genetics of XLID has recently been accelerated
by next-generation DNA sequencing and novel bioinformatics
approaches for variant filtering (de Ligt et al., 2012; Rauch
et al., 2012; Redin et al., 2014; Hu et al., 2015; Tzschach
et al., 2015). However, analysis of large exome data sets
from the general population has also revealed a number of
‘‘XLID genes’’ where truncating variants or previously published
‘‘mutations’’ are observed at a relatively high frequency in
normal controls, calling into question whether they are indeed
causal. For example, recent studies questioned the implication of
AGTR2, MAGT1, ZNF674, SRPX2, ATP6AP2, ARHGEF6, NXF5,
ZCCHC12, ZNF41, ZNF81 and RAB40AL in XLID (Piton et al.,
2013; Ołdak et al., 2014). This highlights the vital importance
of structure-function analyses for validating potentially disease-
causing variants.
In this study, we have combined next-generation sequencing,
variant filtering and structure-function assays to resolve the
cause of XLID in a large family known as MRX78 (de
Vries et al., 2002). A previous investigation of the MRX78
family revealed linkage to the short arm of chromosome X
(Xp11.4-p11.23; de Vries et al., 2002). We present compelling
evidence that the likely cause of XLID in the extended MRX78
pedigree with six affected males and seven affected females in
four generations is a missense mutation in the known XLID
gene IQSEC2 (MIM∗300522; Shoubridge et al., 2010) encoding
a neuronal ArfGEF (known as IQSEC2, BRAG1 and IQ-
ArfGEF) involved in cytoskeletal organization, dendritic spine
morphology and excitatory synaptic organization, along with a
review of previously published IQSEC2-related XLID patients.
MATERIALS AND METHODS
Genetic Analysis
Written informed consent was obtained from the legal guardians
of patients III-5 and III-8 regarding next-generation sequencing.
This study was declared exempt from approval by the medical
ethics committee of the Erasmus MC University Medical
Center (decision MEC-2012-387). Confirmation of the mutation
in the additional family members was performed on DNA
previously obtained and used for diagnostic purposes and
was carried out according to Erasmus MC University Medical
Center regulations for secondary use of tissue after diagnostic
procedures. In addition, patients or legal guardians were
informed and gave verbal consent to use remaining samples
for scientific research. X-chromosome exome resequencing and
bioinformatics analysis was performed as recently described (Hu
et al., 2014, 2015). DNA from the affected male individual
III-8 was used for constructing the sequencing library using
the Illumina Genomic DNA Single End Sample Prep kit
(Illumina, San Diego, CA, USA). Enrichment of the X-
chromosomal exome was then performed using the Agilent
SureSelect Human X Chromosome Kit (Agilent, Santa Clara,
CA, USA), which contains 47,657 RNA baits for 7591 exons
of 745 genes of the human X chromosome. Single-end
deep sequencing was performed on the Illumina Genome
Analyzer GAIIx (Illumina, San Diego, CA, USA). Reads were
subsequently mapped to the human reference genome (hg18
without random fragments) with RazerS (Weese et al., 2009)
tolerating a sequence difference up to 5 bp per read. We
applied the split mapping tool SplazerS (version1.0; Emde
et al., 2012) in order to detect short insertions (<30 bp)
and larger deletions (<50 kb) from unmapped and indel-
containing reads. In addition, large insertions/deletions were
predicted using ExomeCopy (Love et al., 2011) by analysing
changes in depth of coverage along the targeted regions. Single-
nucleotide polymorphisms (SNPs) and short indels (<5 bp)
were called with snpStore. In parallel, we used the Medical
Resequencing Analysis Pipeline (MERAP; Hu et al., 2014).
Here, the mapping was performed using SOAP2 allowing at
most two mismatches, and requiring at least four reads for
single-nucleotide variant (SNV) and indel detection. For both
approaches all sequence variants were screened against public
databases [dbSNP138, 1000 Genomes project, Exome Variant
Server (ESP6500)], and the in-house database of the Max
Planck Institute, Berlin for annotating likely non-pathogenic and
previously reported neutral variants. In addition, the OMIM
catalog and the Human Gene Mutation Database (HGMD) were
used as a filter to identify all previously described mutations. PCR
primers for mutation confirmation and segregation analysis were
IQSEC2-D221F 5′-cctcttgctgtccttttcca-3′ and IQSEC2-D221R
5′-tgggcccaaaattagttcaa-3′.
Building a Homology Model of Human
IQSEC2
Structural templates for homology modeling of IQSEC2 were
determined using HHPred1 (Söding et al., 2005). Homology
modeling of the Sec7 and PH domains of IQSEC2 relied on three
template crystal structures. The human BIG1 SEC7 domain (PDB
ID: 3LTL, sequence identity 42%) was used to model the SEC7
domain, human GEP100 IQ motif (PDB ID: 3QWM, sequence
identity 70%) was used to model the PH domain and finally,
the mouse Grp1 Arf GTPase exchange factor (PDB ID: 2R0D;
DiNitto et al., 2007) was used to model parts of both the Sec7
and PH domains and to guide the orientation of the domains
1http://toolkit.tuebingen.mpg.de/hhpred
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relative to each other (overall sequence identity of 38%). A model
of the 24 amino acid linker between the SEC7 and PH domains
(residues 942–966) was calculated using I-TASSER2 (Zhang,
2008; Roy et al., 2010, 2012), which predicts proteins structure
from sequence using multiple threading alignments via LOMETS
(Wu and Zhang, 2007) and iterative assembly simulations based
on structural templates or by ab initio modeling. For this
linker, I-TASSER built a model with a straight α-helix, based
on structural coordinates from various homologous structures
in PDB (PDB IDs: 3CC2G, 2KEGA, 1K73I, 1S72G, 1M90I,
1QVFG) with sequence similarities of 21–28% [confidence score
(C-score) of −0.9]. This was consistent with secondary structure
prediction methods; PSIPRED3 (Jones, 1999) and RaptorX4
(Källberg et al., 2012), which predicted residues 948–960 to
form a helix with a high confidence (>80%). Single pairwise,
sequence-structure alignments were calculated using HHPred,
then the alignments were combined manually to generate one
multiple alignment of the entire IQSEC2 sequence with the
four template structure sequences (three PDB structures and
one model of the linker). Based on this alignment, 30 models
were generated using MODELLER-9.10 and assessed with the
Discrete Optimized Protein Energy (DOPE) statistical potential
score (Shen and Sali, 2006). The model with the lowest DOPE
score was selected as representative. The p.A789V mutation
was modeled with the swapaa command in Chimera (Pettersen
et al., 2004) using the Dunbrack backbone-dependent rotamer
library (Dunbrack, 2002) and taking into account the lowest
clash score, highest number of H-bonds and highest rotamer
probability.
Site-Directed Mutagenesis and Expression
Constructs
The missense mutation c.C2366T, p.A789V was introduced into
full-length human pCAGGS-IQSEC2 using the QuikChange site-
directed mutagenesis kit (Agilent) and the primers hIQSEC2-
A789V1 5′-accggtgggagtggttcacttcatcctgg-3′ and hIQSEC2-A789
V2 5′-ccaggatgaagtgaaccactcccaccggt-3′. Expression constructs
were verified by Sanger DNA sequencing of the entire coding
region.
Arf Activation Assay
Golgi-localized, ear-containing ARF-binding protein 3 (GGA3)
pull-down of activated ARF GTPases was performed as
previously described in Shoubridge et al. (2010). Plasmids
encoding HA-ARF6 in pXS and FLAG-tagged wild-type IQSEC2,
IQSEC2A789V or IQSEC2E849K in pCAGGS were co-transfected
into HEK293 cells with Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA). Cells were harvested in lysis buffer (50 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 0.1% SDS, 0.5%
sodium deoxycholate, 1% Triton X-100, 10% glycerol, and HALT
protease inhibitor cocktail (Pierce, Rockford, IL, USA), and
lysates were incubated with GST:GGA3 coupled to glutathione
beads. Beads were washed in lysis buffer without protease
2http://zhanglab.ccmb.med.umich.edu/I-TASSER
3http://bioinf.cs.ucl.ac.uk/psipred/
4http://raptorx.uchicago.edu/
inhibitors and boiled in SDS-PAGE buffer. Samples were run
on SDS-PAGE gels and transferred to PVDF membranes. The
membranes were probed with primary antibodies against HA
(Covance, Princeton, NJ, USA) or FLAG (Sigma, St. Louis,
MO, USA) and IRDye secondary antibodies and visualized and
quantified with the use of a LiCor Odyssey Infrared Imaging
System. The fluorescence intensity of each of the bands was
quantified with Image Studio Lite. ARF6-GTP bands were
normalized to total ARF6 expression for each of the conditions,
and then the ratio of normalized ARF6-GTP to normalized
ARF6 was calculated for wild-type IQSEC2, IQSEC2A789V and
IQSEC2E849K. The GGA pulldown assay was assessed by one-way
ANOVA followed by Tukey’s Multiple Comparison Test for post
hoc analysis.
RESULTS
Clinical Re-assessment of Family MRX78
The revised pedigree of the MRX78 family is depicted in
Figure 1A and a summary with clinical findings is presented
in Table 1. Individual I-2 had mild ID and was illiterate. She
had a stroke at age 71 and developed dementia thereafter. She
passed away at age 80. She gave birth to 15 children; two were
stillborn. Two sons and a daughter died in childhood, they were
said to be ‘‘handicapped’’, one son had spina bifida. All children
were placed in foster homes. She had two brothers with normal
cognition and three sisters. II-2 had mild ID with difficulty
reading and writing. II-6 has ID. II-8 has learning difficulties
and is unable to read or write. Her chromosome studies were
normal and urine analysis was negative for MAO-A deficiency.
Her husband (II-7) also had learning difficulties/ID. II-9 has
severe ID, intractable epilepsy and does not speak, or interact
socially. He does like physical contact (e.g., holding hands) and
responds to his name. He developed walking difficulties in his
fifties, with unstable gait (‘‘as a drunk person’’) and is now
wheelchair bound. There is no tremor and his vision and hearing
are good. III-1 and III-2: These brothers both have severe ID.
They do not seem to recognize a familiar person and have no
speech. They can be physically aggressive towards caretakers, and
both are on levomepromazine therapy. Vision and hearing are
normal. Urine metabolic investigations were normal, and there
was no MAO-A deficiency. Subject III-1 has had one seizure as
a teenager. III-3 has moderate ID and no seizures. His height is
176.5 cm, occipital frontal circumference (OFC) 55 cm, and he
has no dysmorphic features. Urine metabolic investigations were
normal, and MAO-A deficiency was excluded. III-4 had learning
difficulties. III-5 was born at term after an uncomplicated
pregnancy with birth weight 4400 grams. Developmental delay
was evident from early age. At age 12 extensive investigations
were performed. At this time he had a moderate to severe
ID and severe behavioral problems, refractory to treatment,
including Haldol and valproic acid. An EEG showed a diffuse
encephalopathy, without epileptic discharges, a brain CT-scan
was normal (data not shown). IQ testing age 16 years showed
verbal IQ (VIQ) compatible to age 4.7 years, and performance
IQ (PIQ) compatible to 4.1 years. He showed minor regression
when he was retested at 28 years with the Wechsler Intelligence
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FIGURE 1 | Identification of an A789V mutation in IQSEC2 in family MRX78. (A) Pedigree of the MRX78 family, which has been updated. Open symbols
represent normal individuals, filled gray square represents a male with learning disabilities, filled black squares represent more severely affected males, filled gray
circles represent affected females. Individual generations are numbered with Roman numerals on the left of each pedigree. Individuals tested for the nucleotide
substitution in each family are indicated either A (mutant allele) or G (normal allele). (B) DNA sequence electropherograms for the chrX:53277996 G>A mutation
reported in this study. (C) Schematic of the human IQSEC2 protein with a regulatory IQ-like motif, a catalytic Sec7 domain, a pleckstrin homology (PH) domain and a
PDZ binding motif. The relative locations of all currently known mutations in IQSEC2 are shown (see also Table 2), ∗ indicates that p.S861T is predicted to abolish a
splice site. (D) Sequence alignments of IQSEC1, IQSEC2 and IQSEC3 showing the location of missense mutations in the Sec7 domain. Note that IQSEC2 Sec7
domain mutations do not affect predicted GTPase binding residues (bold green type below alignments) as defined in the structure of the related Sec7 domain in the
ArfGEF ARNO. Bold type indicates amino acids that are identical in all four sequences.
Scale (WISC) when his cognitive abilities were compatible to
a 3.5 year-old. His social-emotional functioning was lower,
at the level of a 6–18-month-old. Currently, at age 43 years,
he is physically healthy, height is 181 cm and weight 90 kg.
Neurological examination showed no abnormalities. He has good
hearing and vision, with only mild hypermetropia (1.25 dpt).
He is independent in basic daily activities such as dressing
and eating, but needs incentive. He is on risperidone treatment
(0.5 mg twice daily) and laxantia. He communicates mostly
through pictograms. He is quiet and introverted, with occasional
verbal aggression, but not physical. He likes puzzles. He is easily
distracted. He is suspected of autism spectrum disorder but has
not been formally tested. Laboratory investigations in the past,
including metabolic screen, Fragile X and chromosome studies
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 January 2016 | Volume 8 | Article 85
Kalscheuer et al. IQSEC2 Mutation in MRX78
TABLE 1 | Summary of clinical features present in affected males and females in the MRX78 family.
Subject Gender Intellectual disability Epilepsy Behavioral problems
I-2 F Mild, illiterate – –
II-2 F Mild – –
II-6 F Present – –
II-7 M Learning difficulties∗ – –
II-8 F Mild – –
II-9 M Severe, does not speak Present Does not interact socially
III-1 M Severe, does not speak One seizure as a teenager Aggressive against others
III-2 M Severe, does not speak – Aggressive against others
III-3 M Moderate – –
III-4 F Learning difficulties – –
III-5 M Moderate-severe Diffuse encephalopathy without
epileptic discharge
Occasional verbal aggression, suspected of
ASD but not formally tested
III-6 F Learning difficulties – –
III-8 M Severe – Pervasive developmental disorder, ASD,
severe aggressive outbursts against objects
IV-1 F Learning difficulties – –
∗Cause unknown.
were normal. III-6: During pregnancy her mother had several
hospital admissions due to vaginal bleeding and premature
contractions. Chromosome studies in chorion villi biopsy were
normal (46, XX). She was born at term, with cleft lip/palate,
her birth weight was 2785 grams and length 50 cm. She has
mild learning difficulties, her OFC is 54 cm. She has three
daughters, in whom no molecular testing was performed. She
has had two first trimester miscarriages. The eldest daughter
(IV:1) was born at 38 weeks of gestation, BW 2900 gram. She
has learning difficulties and receives special education, her OFC
is 57 cm. She is overweight. Her second daughter (IV:2) was
born with ventricular septal defect, her BW was 2700 grams
after 38 weeks of gestation. She has normal development, and no
learning difficulties. Chromosome studies in chorion villi biopsy
in the middle and youngest daughter were normal (46, XX). The
youngest is still too young to assess her development. III-8: the
pregnancy was complicated with episodes of vaginal bleeding and
premature contractions. Developmental delay became evident
in the first year of life. He had psychiatric consultation at
age 11, due to problematic and aggressive behavior. Two years
later he was diagnosed with a pervasive developmental disorder.
Currently, at age 36, he has severe ID and autism spectrum
disorder. He has a fixation on mirrors and sunshades, and will
go around and close them. He has shown severe aggressive
outbursts with destructive behavior towards furniture and other
objects. He receives risperidone 2.5 mg daily. WISC testing age
20 years showed VIQ compatible to age 4.7 years, and PIQ
compatible to 4.1 years. He was last tested at age 34 (Vineland
Adaptive Behavior Scale) and he had shown mild regression
over a 3-year period. His adaptive skills are now at a level for
communication of a 1 year 7 month old, for daily activities at a
3-year-old level, for motor skills at a 1 year 5 month old level, and
socialization skills compatible to a 10 month old. He is physically
in good health. He underwent adenotomy, strabismus surgery,
and excision of a follicular jaw cyst. His current height is 177
cm, and weight 82 kg. Neurological examination showed only
brisk reflexes of the lower extremities. He has normal hearing
and myopia, with normal media and fundi. Fragile X testing was
negative.
Identification of a p.A789V Mutation in
IQSEC2 in Family MRX78
X-chromosome exome sequencing followed by bioinformatics
analysis and filtering against publicly available datasets revealed
three novel missense changes: IQSEC2, chrX:53277996G>A,
p.A789V, consensus score 4.06, predicted as probably damaging
(PolyPhen-2) and damaging (SIFT) with a CADD score of 19;
TXLNG, chrX:16859571G>C, p.E423D with a low conservation
score (0.02) and predicted as benign (Polyphen-2) and tolerated
(SIFT) and CADD of 16; WAS, chrX:48542814T>G, donor,
conservation score 3.69, and CADD of 12. This strongly
suggested that the novel missense mutation identified in IQSEC2
could be responsible for XLID in this family. Subsequent
segregation analysis using Sanger DNA sequencing indicated that
the IQSEC2 chrX:53277996G>A variant co-segregated with the
XLID phenotype in all individuals tested (Figures 1A,B).
IQSEC2 p.A789V Mutation is Predicted to
Disrupt SEC7 Domain Folding
IQSEC2 has a multi-domain structure consisting of a regulatory
IQ-like motif, a catalytic Sec7 domain, a pleckstrin homology
(PH) domain and a PDZ binding motif (Figure 1C). Residue
A789 is located in the catalytic Sec7 domain of IQSEC2 and
is highly conserved within IQSEC1–3 (Figure 1D), whereas
seven out of nine rare missense variants identified in this
domain in normal controls (ExAC database5) are mostly present
in single individual, and are not conserved residues between
IQSEC1−IQSEC3. It is also notable that 3 of 4 previously
reported IQSEC2 missense mutations identified in XLID families
are located in the Sec7 domain (Figure 1C; Shoubridge et al.,
2010), including the previously investigated R863W mutation
5http://exac.broadinstitute.org/gene/ENSG00000124313
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present in the large family MRX1. This R863 residue is the
only highly conserved amino acid that is substituted to R863Q
in a single normal female. To visualize the potential structural
consequences of the p.A789V change, we built a comparative
model of the IQSEC2 Sec7 and PH domains using the structures
of three sequence-related ArfGEFs: BIG1, GEP100 and Grp1
(PDB ID: 3LTL, 3QWM). The resulting model revealed that
A789 is located on the third short helix of nine in the Sec7
domain, although it is not one of the residues predicted to
interact with Arf GTPases, GDP or Zn2+ binding (Figures 1D,
2A). The third and fourth helices come together closely and
appear to form a hydrophobic pocket. The residues on these two
helices are highly conserved and form a very similar structure
in all Sec7-containing crystal structures in PDB, suggesting that
the interaction between these helices may be of importance for
proper folding of the Sec7 domain. Substitution of alanine at
residue 789 with valine introduces a larger side-chain into this
packed hydrophobic pocket between helices, which is predicted
to cause numerous clashes with surrounding side-chains and/or
backbones of residues V818, C821 and V822 (Figure 2B).
Mutation p.A789V in IQSEC2 Disrupts
ArfGEF Activity
We also tested the GEF activity of full-length IQSEC2 and the
IQSEC2A789V mutant in a cellular model using a pull-down assay
using the adaptor protein Golgi-localized, ear-containing ARF-
binding protein 3 (GGA3; Figure 3A). GGAs specifically interact
with active, GTP-bound ARF but do not interact with inactive
ARF GTPases. As a control, we used the IQSEC2E849K dominant-
negative mutation, which reduces the exchange activity of
the IQSEC2 Sec7 domain by several orders of magnitude
(Shoubridge et al., 2010). Co-transfection of ARF6 with wild-type
IQSEC2 resulted in a∼5-fold increase (5.5± 0.91, mean± SEM,
n = 3) in GTP-bound ARF6, but only a 2.5- to 1-fold increase
when expressed with IQSEC2A789V (2.5 ± 0.19) or IQSEC2E849K
(1.2 ± 0.19) respectively (Figures 3B,C). This is consistent with
a significant loss of ArfGEF activity in the IQSEC2A789V mutant.
It is also noteworthy that the IQSEC2A789V mutation does not
appear to affect protein stability (Figure 3B), at least in cellular
models.
DISCUSSION
This study reports the identification and functional
characterization of a novel mutation (c.C2366T, p.A789V)
in IQSEC2 that based on variant filtering and segregation
analysis likely presents the cause of XLID in the large family
MRX78. A previous analysis in this family revealed X-linked
inheritance with linkage to a 15.16 cM region on Xp11 (de
Vries et al., 2002). Using molecular modeling of wild-type
and mutant protein and assays for ArfGEF activity, we were
FIGURE 2 | IQSEC2 A789V mutation is predicted to disrupt SEC7 domain folding. Side views of the molecular models of IQSEC2 Sec7 and PH domains, with
the Sec7 domain in red, the PH domain in blue and the linker between them in gold. Boxed areas show the areas expanded in the inserts to the right. (A) Normal
IQSEC2 structure, and (B) mutant IQSEC2 harboring the p.A789V mutation. Note that the larger valine side-chain in the packed hydrophobic pocket between
helices is predicted to cause numerous clashes with surrounding side-chains and/or backbones of residues V818, C821 and V822, indicating a potential disruption
of the local fold in this region.
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FIGURE 3 | Mutation A789V in IQSEC2 disrupts ArfGEF activity. (A) GGA
pulldown assay: HA-tagged ARF6 and FLAG-tagged wild-type or
IQSEC2A789V or IQSEC2E849K (control) were transfected into HEK293 cells and
lysates were subjected to a pull-down assay with GST:golgi-localized,
ear-containing arf-binding protein 3 (GGA3) to isolate ARF6-GTP. (B) The
precipitates (top row) and lysates (bottom row) were probed with anti-HA to
detect ARF6 and anti-FLAG to detect expression of IQSEC2 (middle row).
(C) ARF6-GTP levels were normalized to total ARF6 levels and are depicted as
the fold-increase over ARF6 transfected with empty vector. The GGA pulldown
assay was assessed by one-way ANOVA (F = 15.69, p < 0.001) followed by
Tukey’s Multiple Comparison Test for post hoc analysis (significance indicated
in C). Error bars in the bottom panel represent the standard error of the mean
(SEM) from three independent experiments. ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001.
able to establish the likely pathomechanism for p.A789V: a
disrupted hydrophobic pocket in the Sec7 domain structure,
leading to loss of IQSEC2 ArfGEF activity. The identification
of IQSEC2 as the causative gene for MRX78 is consistent
with previous studies that have identified IQSEC2 as a
neuronally-expressed ArfGEF with a key role in excitatory
synaptic transmission. At excitatory synapses, IQSEC2 interacts
with multivalent postsynaptic density (PSD) proteins such
as IRSp53 (Sanda et al., 2009) and PSD-95 (Sakagami et al.,
2008), forming a complex with N-methyl-D-aspartate (NMDA)
receptors.
A recent reassessment of the MRX78 family by one of
the co-authors (RO) revealed that except for one all affected
males presented with moderate to severe ID, several affected
males did not acquire speech skills and presented with
behavioral disturbances. Females from this family who carry
the mutation on one of her X-chromosomes presented with
learning difficulties or mild ID. A summary with genetic findings
and clinical presentations of other affected individuals who
carry missense, nonsense, deletions, insertions and complex
rearrangements is given in (Table 2). Shoubridge et al.
(2010) initially reported four missense mutations in IQSEC2
associated with non-syndromic XLID (IQ domain p.R359C, Sec7
domain p.R758Q, p.Q801P and p.R863W). However, seizures,
autistic traits, psychiatric problems and delayed early language
skills were noted in different male individuals in this study.
Furthermore, several de novo deleterious IQSEC2 mutations
have been reported in males and females who presented with
seizure disorders, including Rett-like syndrome and Lennox-
Gastaut syndrome: a frameshift mutation (p.N91Kfs∗112)
and a truncating chromosome breakpoint in intron 1 [46,
X(tX;20)(p11.2;q11.2)] in the N-terminal part of IQSEC2
(Morleo et al., 2008; Olson et al., 2015), a two base pair
deletion resulting in p.C684X (region between IQ-like motif
and Sec7 domain) (Gandomi et al., 2014), two additional
mutations affecting the Sec7 domain (p.R855X and p.S861T
that is predicted to abolish the native splice donor site; Rauch
et al., 2012; Gandomi et al., 2014; Tran Mau-Them et al.,
2014), and one de novo mutation (p.Q1108X) C-terminal to
the PH domain (Allen et al., 2013). Additionally, Tran Mau-
Them et al. (2014) reported two severely affected males with
Rett-like features who carried de novo intragenic duplications,
both of which were thought to disrupt IQSEC2. Furthermore,
a p.I888Afs followed by a subsequent premature stop codon
has been identified in a male with severe non-syndromic ID
(Tzschach et al., 2015). IQSEC2 mutations in ID patients which
affect the PH domain of the protein have also been reported,
including a p.L992X change in a patient with schizophrenia
(Purcell et al., 2014), a de novo p.Q1033X mutation in a
male with severe ID, epilepsy, strabismus and autistic features
(Redin et al., 2014), and a de novo mutation (p.R1055X) in a
female with severe ID, epilepsy and borderline macrocephaly
(Tzschach et al., 2015). A partial de novo duplication of TENM3
inserted into IQSEC2 and subsequent formation of an in-frame
IQSEC2-TENM3 fusion gene was also recently reported. The
resulting disruption of IQSEC2 was thought to contribute to
ID, epilepsy, progressive spasticity, and microcephaly in that
patient (Gilissen et al., 2014). Furthermore, three maternally
inherited duplications with disrupted IQSEC2 in five males who
presented with ID and behavioral disturbances were reported
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TABLE 2 | IQSEC2 mutations and associated phenotypes.
Missense and nonsense mutations
Nucleotide Protein Gender of affected
and inheritance
Reported phenotype Reference
c.1075C>T p.R359C 4M and 1F, maternally
inherited
Mild to moderate ID in males, non-syndromic†, female
with learning difficulties
Shoubridge et al. (2010)
c.2273G>A p.R758Q 8M, maternally inherited Mild ID, non-syndromic† Shoubridge et al. (2010)
c.C2366T p.A789V 6M and 7F (MRX78),
maternally inherited
Moderate to severe ID and behavioral disturbances in
males, mild ID and learning difficulties in females
This study
c.2402A>C p.Q801P 8M and 2F (MRX18),
maternally inherited
Moderate to severe ID in males, non-syndromic†, carrier
females with learning difficulties
Gedeon et al. (1994) and
Shoubridge et al. (2010)
c.2563C>T p.R855X 1M, de novo ID, epilepsy, stereotypic hand movements, strabismus,
language partially acquired but delayed, both language
and motor skills regressed, behavioral disturbances
including self-injury, abnormal MRI
Rauch et al. (2012) and Tran
Mau-Them et al. (2014)
c.2582G>C p.S861T, predicted
to abolish splice site
1M, de novo ID, developmental delay, seizures, hypotonia, vision
impairments, plagiocephaly, autistic-like features, absent
language skills, abnormal MRI
Suthers et al. (1998) and
Gandomi et al. (2014)
c.2587C>T p.R863W 12M (MRX1),
maternally inherited
Moderate ID, non-syndromic† Turner et al. (1971), Suthers
et al. (1998), and Shoubridge
et al. (2010)
c.2975T>A p.L992X 1, gender not reported Schizophrenia Purcell et al. (2014)
c.3097C>T p.Q1033X 1M, de novo Severe ID, no speech, motor developmental delay,
severe epilepsy, strabismus, autistic features
Redin et al. (2014)
c.3322C>T p.Q1108X 1F, de novo Lennox-Gastaut syndrome, global developmental delay Allen et al. (2013)
c.3163C>T p.R1055X 1F, de novo Severe ID, epilepsy, borderline macrocephaly Tzschach et al. (2015)
Small deletions/insertions
Nucleotide Protein Gender and
Inheritance
Reported phenotype Reference
c.273_282del p.N91KfsX112 1F, de novo ID, features of Rett syndrome, no epilepsy, gait
abnormalities, stereotypic hand movements, regression
but did not lose purposeful hand skills, cranial MRI
showed delayed myelination.
Olson et al. (2015)
c.2052_2053delCG p.C684X 1M, de novo ID, hypotonia, strabismus, astigmatism, cortical vision
impairment, hypoplastic corpus callosum, myoclonic
seizures, positional plagiocephaly with mild relative
microcephaly, stereotypic hand movements
Gandomi et al. (2014)
c.2662dup p.I888AfsX16 1M, de novo Severe ID, non-syndromic Tzschach et al. (2015)
Gross deletions and insertions without HUWE1 gene involvement
Nucleotide Gender and
Inheritance
Reported phenotype Reference
Deletion 400 kb also 1F, de novo Severe ID and autistic-behavior Fieremans et al. (2015)
including KDM5C
Duplication 22 kb incl. ex. 3 1M, de novo Severe ID, language partially acquired, midline
stereotypic hand movements, partial epilepsy, regression
of language and motor skills, behavioral disturbances
Tran Mau-Them et al. (2014)
Duplication 42 kb incl. ex. 3–7 1M, de novo Severe ID, postnatal microcephaly, no speech, no
purposeful hand skills, seizures, behavioral disturbances
Tran Mau-Them et al. (2014)
62 kb insertion of TENM3 1F?, de novo Severe ID, microcephaly, epilepsy, progressive Gilissen et al. (2014)
sequence, fusion gene spasticity, small hands and feet, poor vision
Duplication 361 kb with 1M, maternally inherited Language delay and behavioral problems Moey et al. (2015)
disrupted IQSEC2 long isoform
Duplication 403 kb with short 3M, maternally inherited Mild-moderate ID, mild learning difficulties in Moey et al. (2015)
IQSEC2 isoform duplicated one male, autism spectrum disorder, obsessive behavior
Duplication 579 kb, 1M, maternally inherited Global delay, severe expressive speech delay, Moey et al. (2015)
including TSPYL, KDM5C and IQSEC2 behavioral disturbances
(Continued)
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TABLE 2 | (Continued).
Complex rearrangements
Description Reported phenotype Reference
Balanced 46, X, t(X;20) Severe ID, delayed language and motor Morleo et al. (2008)
(p11.2;q11.2) de novo development, infantile spasms, regression
†seizures, autistic traits, psychiatric problems and delayed early language skills were noted in different individuals in this study, although none of these additional phenotypes
were consistent in all affected male individuals in the families studied.
by Moey et al. (2015), and a de novo deletion of IQSEC2 and
the XLID gene KDM5C (MIM∗314690; Jensen et al., 2005) has
been identified in a girl with severe ID and autistic behavior
(Fieremans et al., 2015). Although originally described as non-
syndromic XLID, newly acquired clinical data from the MRX78
family suggests that additional features might be associated with
the IQSEC2 p.A789V mutation, including variable seizures in
males, which is consistent with other reports, and behavioral
disturbances in five out of six affected males. By contrast,
heterozygous female have learning disabilities. As IQSEC2 is
one of the few genes that escape X-inactivation in females
with an expression level similar in males and females (Moey
et al., 2015) we hypothesize that, in these female carriers, the
missense mutation is sufficient to produce symptoms but that
the mutant protein has residual function and in addition that
there is some compensation from the normal allele. This is
in contrast to early truncating mutations in IQSEC2, which in
females are associated with a more severe phenotype including
infantile spasms, epilepsy, autistic features, Lennox Gastaut
syndrome and Rett-like syndrome. Given that in several severely
affected females IQSEC2 is either deleted on one of the X-
chromosomes or the truncating change is located early in
the N-terminus and therefore can be assumed to result in
protein degradation due to nonsense-mediated mRNA decay,
it is unlikely that in these cases the mutations produce a
dominant negative effect. Thus, it is very likely that IQSEC2 is
a dosage-sensitive gene that needs to be tightly regulated for
normal cognitive function in males and females and that IQSEC2
mutations can cause a spectrum of clinical features in both
sexes.
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